Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.3109/10428194.2014.904512 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Design, development and implementation of a national faculty development program to promote CBME in graduate medical education in Switzerland.
GMS J Med Educ
December 2024
University Hospital Zurich, Institute of Anesthesiology, Zurich, Switzerland.
Background: Competency Based Medical Education (CBME) is a global movement in graduate medical training but implementation on a national scale is challenging. One crucial element of fostering CBME is to establish faculty development. We report the design of a national program, the process of implementation, and the results of the first two years.
View Article and Find Full Text PDFCan screening and decontamination procedures performed on an outpatient basis reduce the colonization with Staphylococcus aureus and mitigate associated complications in patients undergoing elective hospital procedures? A controlled intervention study (STAUfrei).
J Hosp Infect
December 2024
Kliniken Landkreis Heidenheim, Heidenheim, Germany.
Background: Staphylococcus aureus (SA) colonisation increases the risk of wound infections in surgical procedures. Prevention strategies to date have focused primarily on the hospital, although there are recommendations for pre-hospital decontamination at home, which can be performed by patients themselves. The current study aimed to shift the process of screening and decontamination of SA (methicillin-resistant S.
View Article and Find Full Text PDFUmbilical abscess caused by Helcococcus kunzii: a case report and literature review.
J Infect Dev Ctries
October 2024
Department of Clinical Laboratory, People's Hospital of Deyang City, Deyang, Sichuan 618000, China.
Introduction: Helcococcus kunzii is a commensal bacterium found in the human skin that seldom causes infection. While there is documentation of abscesses; such as foot, breast, and brain abscesses; caused by H. kunzii, there are no reports of its causing umbilical abscesses.
View Article and Find Full Text PDFReal world effectiveness of early ensitrelvir treatment in patients with SARS-CoV-2, a retrospective case series.
New Microbes New Infect
December 2024
Wal-yan Respiratory Centre, Telethon Kids Institute, University of Western Australia, Nedlands, 6009, Western Australia, Australia.
Background: Ensitrelvir, a 3C-like protease inhibitor, received emergency approval in Japan in November 2022 for treating non-hospitalized patients with mild-to-moderate COVID-19. However, confirmation of its real-world clinical effectiveness is limited.
Methods: This retrospective study evaluated 18 vaccinated outpatients (15 men; median age, 39.
A 54-Year-Old Man With High-Grade Fever, Cough, Dyspnea, and Vesiculobullous Skin Eruptions.
Chest
November 2024
Department of Internal Medicine, Stadtspital Zürich Triemli, Zurich, Switzerland.
A 54-year-old Egyptian man with a 5-day history of worsening cough, high-grade fever, and progressive dyspnea was referred to our hospital. A 3-day course of ceftriaxone provided in an outpatient setting showed no clinical improvement. Medical history was unremarkable, except for bilateral pulmonary embolism diagnosed 3 years earlier.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!